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Cancer cachexia is debilitating and distressing. not only for
the patient. but for the family and friends who feel helpless
to stop their relative 'dissolving before their eves'. Eating is
normally a pleasurable and sociable occasion. which cont-
ributes to a sense of well-being. The normal physiology of
hunger. appetite and satiety continue to be conjectural. What
is known is that the hypothalamus plays a major facilitatory-
and inhibitor- role in hunger and satiety. Feedback from
plasma glucose. free fatty acids. glycerol. amino acids.
peripheral metabolic state and signals from the gastrointes-
tinal tract ensure the fine tuning of calorie intake. distribu-
tion. disposal and storage (Bray & Campfield 1975). Mayer
(1953. 1955. 1957) suggested that blood glucose may be the
link between the supply of nutrients and the hypothalamus.
A 'normal' hunger is a result of physiological changes in the
state of the body's stores of energy and is inhibited by
fullness. a sensation arising from the alimentary canal
(Davidson et al.. 1979). The desire to eat can be seen as a
continuum with appetite at one end and satiety at the other.
with the change occurrng gradually as the meal progresses
(Silverstone & Goodall. 1986).
Cancer cachexia is viewed as a complex syndrome, the
aetiology of which is still uncertain and is often only reversed
when the malignancy is treated effectively (Theologides.
1977). It occurs in one-half to two-thirds of patients with
cancer and has long been recognised as a frequent cause of
death in the cancer patient (Warren. 1932). The symptoms of
cancer cachexia are anorexia, early satiety. loss of body
protein and fat. anaemia and marked asthenia. In addition,
there is an increase in the basal metabolic rate and a corres-
ponding increase in energy expenditure. whilst there is fre-
quently a decreased energy' intake (Theologides. 1979).
Metabolic factors play a role in many patients and may
include, altered carbohydrate and protein metabolism (Hol-
rovde & Reichard. 1981; Young et al.. 1979). selective use
and redistribution of nutrients by tumour cells (Theologides,
1979). alterations of total lipid mobilisation resulting in
elevated free fatty acids (Knox et al.. 1983) and abnormal
synthesis of peptides which may disrupt normal enzyme
activity (Theologides. 1972: Young. 1977). Cancer patients
commonly demonstrate disturbances of glucose metabolism,
Glicksman & Rawson (1956) described this as a diabetic
glucose tolerance. This is characterised by reduced insulin
sensitivity (Lundholm et al.. 1978). increased glucose tur-
nover (Waterhouse. 1974: Holroyde et al.. 1975). altered
insulin production (Kisner et al.. 1978). reduction in the
disappearance rate of i.v. glucose (Marks & Bishop, 1957).
increased gluconeogenesis (Holroyde et al.. 1975), and an
increase in anaerobic glucose consumption (Warbur 1956:
Waterhouse. 1974) which leads to an increased level of lac-
tate and so to an increased rate of Cori cvcling. It has been
postulated that these changes in glucose metabolism may
lead to anorexia, satiety. nausea and weight loss (De Wys.
1979).
A large component of cancer cachexia is reduced food
intake. Theologides (1979) has suggested that in addition to
anorexia. early satiety may be a major factor contributing to
reduced food intake. Early satietv is the desire to eat
associated with an inability to eat more than a few mouth-
fuls, as illustrated in a study carried out by Theologides
(1976) where 10 patients denied anorexia but complained of
easy filling, despite a good initial appetite. This is distinct
from anorexia where there is a reduced desire to eat. Lindsey
& Piper (1985) report that early satiety and nausea were
experienced most frequently by those patients who reported
any appetite-related symptoms. It has been suggested that
early satiety is seen with increasing frequency in those with
advanced cancer. especially following chemotherapy
(Theologides. 1976). however Neilsen et al.. (1980) demon-
strated no significant differences in early satiety between
patients receiving cytotoxic chemotherapy and those not.
This study also showed that there were no significant
differences in tumour type between the numbers of patients
with and without early satiety. When patients were divided
by the presence or not of taste aversions it was found that
80% of those with taste aversions (n = 56) experienced early
satiety compared with 49%0 of those without taste aversion
(n = 77). In addition. those patients experiencing early satiety
found the odours of pork. ham. and coffee significantly less
pleasant than those without early satiety (Neilsen et al..
1980). It has been noted that anorexia and early satiety
appear to worsen during the day (Knox et al.. 1983: Grant.
1986).
The pathogenesis of early satiety on the whole is unclear.
however some theories have been proposed. It may be caused
by direct encroachment of the tumour on the gastrointestinal
tract (Grant. 1986). Theologides (1974) has hypothesised that
early satiety is a result of satiety signals sent by
oropharyngeal receptors. Others have suggested that it may
be due to atrophic changes in the mucosa and muscles of the
stomach, and a reduction in the secretion or activity of
gastrointestinal enzymes which may lead to delayed gastric
emptying. slowing in peristalsis. and sustained stimulation of
receptors in the gastrointestinal tract, and. ultimately. in
early satiety and a decreased stimulation of appetite (Knox et
al.. 1983: Grant, 1986; Lindsey. 1986). De Wys (1985) has
suggested that the increase in blood glucose level seen in
cancer patients may delay gastric emptying. resulting in a
prolonged sense of fullness and further suppression of
appetite. This pattern of elevation of blood glucose may
partly explain the reduced appetite for meals other than
breakfast. as blood glucose will have had the time to return
to normal overnight. There may also, of course. be a
psychological component to satiety and anorexia.
Morrison (1984) carried out a study to look at the dist-
nrbution of food intake in two rat-tumour models. It was
found that there was a reduction in both the average size of
the meals and frequency of feeding. On the basis of these
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data it was hypotbesised that early satiety may be a major
contributing factor to decreased food intake in cancer
patients.
Tlhis study has been carried out to test this hypothesis in
patients with advanced cancer, attending the Medical
Oncology Department at the Homerton Hospital.
Patie.s and metods
Sixty-one previously untreated patients with advanced cancer
were studied; 32 complained of anorexia, with or without
weight loss, and 29 subjectively assessed their appetite to be
normal, and acted as controls. Anorexia was defined as a
subjective loss of appetite as assessed by the patients
themselves. There were a wide variety of tumour types: 36
lung cancer, five mesothelioma, four colon cancer, three
adenocarcinoma of unknown origin and 13 others. Those
with gastric involvement/mechanical problems were excluded.
The distribution of tumour types was similar within the two
groups.
In order to assess appetite, and so assess the incidence of
early satiety, patients were starved from midnight to 2 p.m.
the following day, and hunger, physical emptiness, mood,
and mental activity were measured using visual analogue
scales (VAS), described by Silverstone & Goodall (1986),
who showed these to be a reliable and valid way of subjec-
tively assessing appetite. The scales were filed in at 08.00,
10.00, 12.00 and 14.00, whereafter patients were allowed to
eat as much as they wanted. The amount of food consumed
was recorded and classified by the investigator as very small,
small, medium or large. Fasting blood glucose levels were
also measured at 08.00 and 14.00 to ascertain if those
patients with anorexia had a raised blood sugar, as this may
in part explain the differences in appetite.
Results
Forty seven men and 14 women were entered into the study.
The mean age of the patients studied was 59 years
(range = 38-76). Initially, patients were subdivided into a
normal appetite (NA) and anorexic (Al) group, according to
their own appetite rating. It was apparent that there was a
subgroup of patients in the anorexic group, who showed a
marked increase in hunger across the study period, but whose
food intake at the end ofthe study was rated as small or very
small. The anorexic group was therefore subdivided into an
early satiety (ES) group (hunger rating increase across study
>75% with final VAS hunger score >6.5), and an anorexic
group (A2) with a less marked increase in hunger. Although
the hunger rating for the early satiety group at the end of the
study was very similar to the normal appetite group, all of
the early satiety patients had small or very small food intake,
compared with five of the 29 normal appetite patients
P = 0.00004, Fisher's exact test). In contrast, when those
with anorexia (A2) and early satiety are compared; 16/26 of
the anorexia (A2) group versus 6/6 of the early satiety group
had a small or very small food intake (P= 0.14 Fishers's
exact test).
The repective mean visual analogue ratings (including
standard error of the mean (SEM)) are shown for hunger
(Figure 1), emptiness (Figure 2), mood (Figure 3) and mental
activity (Figure 4) for the patients with NA, A2 and ES.
Each of the three groups experienced a significant increase in
hunger across the study period (P<0.001, for NA, A2 and
ES, paired t-test).
For the two groups, NA and Al, two-way analysis of
variance was used to look at the effect of time and groups on
the four VAS parameters. There was a significant difference
between the two groups in hunger score (t = 6.42, P<0.001)
and a trend towards icreased emptiness in the NA group,
which just reached statistical signficance (t = 2.41, P = 0.02).
There was no significant difference between the two groups in
either mental activity or mood (t=0.18 P>0.85, t=0.73
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P= 0.47 respectively), and no difference across the study
period in these two parameters within the two groups (mood
P = 0.94, mental activity P = 0.76).
These factors were reanalysed, using analysis of variance,
considering the patients as three groups, NA, A2 and ES.
For hunger there was an effect ofgroup (P<0.001) and time
(P<0.001). From this model, adjusting for time point, the
differences between A2 and ES (t = 2.59, P<0.02) and NA
and A2 (t= 6.97, P<.001) were significant, but the
difference between NA and ES was not significant (t= 1.37,
P>0.1). For emptiness and mood the group effect was
significant (emptiness P<0.001, mood P<0.001). In both
cases the difference between A2 and ES was significant (emp-
tiness t = 3.46, P<0.001, Mood t = 4.15 P<0.001). The
difference between NA and ES was highly significant for
mood (t= 3.88, P= <0.001) but was not significant for
emptiness (t = 1.53, P>0.1). There was also a significant
difference between NA and A2 for emptiness (t = 3.38
P<0.001), but not for mood (t = 0.514 P>0.2). For mental
activity there was neither a group (P = 0.098) nor a time
(P = 0.76) effect. However there was a significant difference
between those with A2 and ES (t= 2.17 P<0.05)
Using the Mann-Whitney U Test no differences were
detected between those with NA and A2 at either time point
(08.00, P = 0.8, 14.00, P = 0.41) nor between those with NA
and ES (08.00, P = 0.24, 14.00, P = 0.4).
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The VAS scales showed a difference between NA and Al fo
hunger and emptiness, but not for mental activity and mood
When the Al group was subdivided into A2 and ES it i
apparent from Figures 1, 2 and 3 that there were difference
between those patients with A2 and those with ES in term
of hunger, emptiness, mood and mental activity.
As a group those with ES showed a significant difference il
hunger rating from those with NA and anorexia. At the star
of the study patients experiencing ES had a hunger ratin,
similar to that of those with anorexia. However they the
demonstrated a marked increase in hunger, which reacho
the level of those with NA. Additionally, those with ES wer
significantly more empty and miserable and sleepy than thos
patients classified as anorexic (A2).
In future studies a measurement of psychological statu
should be included as it would be helpful to know if th
patients with ES are more miserable as a result of the in
creased hunger, emptiness and reduced food intake, or vic
versa. In addition, a study which contains larger numbers
patients with ES may provide more information.
The VAS enabled patients with a normal appetite
anorexia and early satiety to be clearly distinguished in thre
of the four parameters. Early satiety occurred in 10% (6/61)
patients. The incidence was lower in this study when com-
pared with the figures from previously published studies
(Table I). However these studies used symptom checklists to
assess any nutritional problems, rather than using a study
design which incorporates the objective experimental assess-
ment of hunger, as in this study. Some of the difference in
the incidence of early satiety may be explained by the
differing definitions of this complaint: it has been variously
described as 'easy filling', 'abdominal fullness', 'fill up quick-
ly' and 'feeling full after having eaten only a little'. Only one
of the studies listed (Theologides, 1976) included in their
definition that patients have a reduced intake despite having
a good appetite. All patients in this study who demonstrated
early satiety complained of anorexia; despite this their hunger
rating rose markedly when they were starved. This would
seem to suggest that these patients' perception of their
appetite was based on the amount they ate rather than the
hunger that they experienced, a factor confirmed by the small
amount of food intake at the end of the study.
In this study the fasting blood glucose levels did not
significantly change. This supports the findings of previous
investigators (DeWys, 1977; Marks, 1956, 1957), who report
that the fasting blood sugars of the cancer patients, anorectic
or non-anorectic, did not differ significantly from that of
tumour-free controls.
Early satiety is a difficult problem to both detect and treat.
There are currently no well recognised treatments and man-
agement is usually palliative. Breakfast has been reported to
be the best tolerated meal of the day and the patient should
be encouraged to make the most of this meal. Welch et al.
(1985) have reported that, in healthy volunteers, ileal
infusions of corn oil emulsions delayed gastric emptying
compared with ileal infusion of albumen and saline. They
suggest that lipid may interact with ileal receptors to induce
early satiety. Rosenbaum et al. (1981) suggest that, for this
reason, fatty foods should be avoided and replaced by sweet
or starchy foods. In addition, small but frequent meals are
recommended.
In a small pilot study metoclopramide has been shown to
improve delayed gastric emptying, and improve gastrointes-
tinal symptoms experienced by cancer patients (Shivshanker
et al., 1984). More recently, cisapride, a non-dopaminolytic
motility-enhancing agent, has been licensed for use in Brit-
ain to alleviate early satiety. In a study comparing the
efficacy of metoclopramide and cisapride on gastric empty-
ing in patients with non-malignant early satiety, it was
found that both drugs accelerated the evacuation of the
meal in cases of delayed gastric emptying. However, cisa-
pride shortened the initial emptying time lag and was
superior to metoclopramide in this respect (Ghigliani et al.,
1987). It may be that cisapride and metoclopramide would
be useful agents to offer cancer patients suffering this dis-
)r tressing symptom.
1. The results of this study seem to suggest that early satiety
is is a major cause of reduced intake in only a small minority of
s patients with cancer. Our experience suggests that for many
is of the patients the symptom may not be noticed, especially
by the patients themselves, who, in this study, mistook it for
n loss of appetite. It may be that health care professionals need
rt to ask more specificaly about early satiety, as its manage-
g ment may be different from that for other nutritional prob-
fn lems.
d
re Table I Previously reported incidence of early satiety
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Author and year Defuition of early satietv Incidence
DeWys et al., 1981 'Fill up quckly' 13% (22/169)
Fanelli et al., 1986 None given 47% (21/45)
Grosvenor et al., 1989 'Abdominal fullness' 61% (155/254)
Lindsey & Piper, 1985 'Feeling full after having 20% (2/10)
eaten only a little' at study start
Neilson et al., 1980 None given 62% (82/133)
Tbeologides, 1976 'Appetite still good with 39% (10/39)
easy filing'
I
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